EXACT Therapeutics AS (DE:56F) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EXACT Therapeutics AS has decided not to proceed with its planned Subsequent Offering of new shares and warrants after successfully raising NOK 145 million through a Private Placement. The company’s shares have been trading at or below the subscription price, providing shareholders ample opportunity to mitigate dilution effects. This decision reflects the company’s strategic adjustment based on current market conditions.
For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.